Calcium potentiates the effect of estradiol on PGF2α production in the bovine endometrium by Bertan Membrive, Claudia M et al.
  Universidade de São Paulo
 
2014-05-05
 
Calcium potentiates the effect of estradiol on
PGF2 production in the bovine endometrium
 
 
Journal of Animal Science and Biotechnology, 2014 May 05;5(1):25
http://dx.doi.org/10.1186/2049-1891-5-25
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Departamento de Reprodução Animal - FMVZ/VRA Artigos e Materiais de Revistas Científicas - FZEA/ZMV
RESEARCH Open Access
Calcium potentiates the effect of estradiol on
PGF2α production in the bovine endometrium
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Abstract
Background: Estradiol (E2) is required for luteolysis in cows and its injection stimulates prostaglandin F2α (PGF2α)
release. The main goal of our study was to investigate the ability of endometrial explants and cells treated with E2
and the calcium ionophore (CI) A23187 to synthesize PGF2α.
Results: Treatment with E2 in vivo resulted in a 48.4% increase of PGF2α production by endometrial explants
treated in vitro with A23187. Production of PGF2α was better stimulated with A23187 at concentrations of 10−6 and
10−5 mol/L compared with other concentrations used. The concentration of PGF2α for untreated bovine
endometrial cell cultures was 33.1 pg/mL, while for cultures treated with E2, A23187, or a combination of E2 and
A23187, the PGF2α concentration was 32.5, 92.4 and 145.6 pg/mL, respectively.
Conclusions: Treatment with A23187 tended to stimulate PGF2α production. In the presence of E2, A23187
significantly stimulated PGF2α synthesis. It appears that A23187 potentiates the effects of E2 with respect to
synthesis of endometrial PGF2α in cattle.
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Background
In cattle, administration of 17β-estradiol (E2; 3 mg) as
early as day 13 of the estrous cycle causes an increase
in the plasma concentration of 13,14-dihydro-15-keto-
prostaglandin F2α (PGFM), the main metabolite of PGF2α
[1,2]. Consistently, ablation of ovarian follicles, which
causes a decrease in plasma concentrations of E2, delays
luteolysis in ruminants [3-5]. E2 is capable of inducing
endometrial synthesis of PGF2α [6]; furthermore, E2 can
induce luteolysis [7].
The endometrial synthesis of PGF2α results from a com-
plex cascade of highly coordinated events. Arachidonic acid
(AA), stored in the phospholipid membranes, is the pri-
mary precursor of prostaglandins [8]. Oxytocin (OT), acting
through its receptor on the endometrial cell membrane, ac-
tivates a guanosine nucleotide-binding protein (G protein),
which promotes the activation of phospholipase C (PLC)
[9]. PLC then cleaves phosphatidylinositol triphosphate
into inositol triphosphate (IP3) and diacylglycerol (DAG).
IP3 binds to receptors on the endoplasmic reticulum,
promoting an increase in cytoplasmic calcium concentra-
tion. DAG activates protein kinase C (PKC), a serine/threo-
nine kinase that is dependent on calcium for activation.
Activated PKC phosphorylates phospholipase A2 (PLA2).
The IP3-induced increase in cytosolic calcium stimulates
calcium-dependent PLA2 activity [10]. PLA2 preferentially
cleaves the sn-2 position of phosphatidylcholine, releasing
AA [11]. The free AA is then converted into prostaglandin
H2 (PGH2) by prostaglandin endoperoxide synthase 2
(PTGS2). Finally, PGH2 is converted into PGF2α by PGF
synthases, such as Aldo-keto reductase family 1 member
C1 (AKR1C1). Calcium is a known cofactor of PKC and
PLA2, which are enzymes involved in PGF2α production.
Although the proteins involved in the synthesis of PGF2α
have been identified, the role of E2 in this process remains
unknown.
The main goal of our study was to determine the ability
of endometrial explants and cells to synthesize PGF2α.
Specifically, we sought to evaluate the capacity of E2, when
administered in vivo, to stimulate PGF2α synthesis in
endometrial explants incubated with a calcium ionophore
(CI), melittin or oxytocin. We also sought to determine
the CI dose that was capable of stimulating the synthesis
of PGF2α in cultured endometrial cells, and to evaluate
* Correspondence: binelli@usp.br
2Department of Animal Reproduction, School of Veterinary Medicine and
Animal Science, University of São Paulo, São Paulo, Brazil
Full list of author information is available at the end of the article
JOURNAL OF ANIMAL SCIENCE
AND BIOTECHNOLOGY
© 2014 Bertan Membrive et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Bertan Membrive et al. Journal of Animal Science and Biotechnology 2014, 5:25
http://www.jasbsci.com/content/5/1/25
the capacity of bovine endometrial (BEND) cells to
synthesize PGF2α following treatment with E2 and/or
a CI.
Methods
Experiment 1
We used 13 cyclic cross-bred beef heifers (B. taurus × B.
indicus) in our study. Animals procedures were approved
by Ethics and Animal Handling Committee of the Univer-
sidade de São Paulo. Animals were fed pasture (Brachiaria
decumbens var. marandu) supplemented with minerals
and had access to water ad libitum. Animals were im-
planted with a device containing 1 g of P4 (CIDR®, Pfizer,
USA) along with an intramuscular injection of gonadore-
lin (100 μg; Fertagil®, Intervet, The Netherlands) on the
first day of the synchronization protocol. Devices were
removed 7 days later and cows were administered D-
cloprostenol (150 μg; Preloban®, Intervet) intramuscularly
and were marked on the tailhead using an All-Weather
Paintstik® (LA-CO Industries Inc., USA). Estrous behavior
was observed twice daily for 48–120 h after PGF2α was
injected. The start of standing estrus was considered day 0
of the estrous cycle (day 0). On day 6, an ultrasonographic
examination was performed (Aloka, SSD-500, linear probe
7.50 MHz), and females with a dominant follicle ≥7.5 mm
received an intramuscular injection of gonadorelin (100 μg;
Fertagil®, Intervet, The Netherlands) to induce ovulation
of the dominant follicle and promote the emergence of a
new follicular wave [12]. Ultrasonographic examination
was performed to verify the presence of an accessory cor-
pus luteum on day 16 of the cycle. Heifers were paired ac-
cording to the day of standing estrus and randomly
chosen for intravenous treatment with 0 (n = 6) or 3 mg of
E2 (n = 7) on day 17. At 2 h post-treatment, animals were
stunned by cerebral concussion from a pneumatic pistol
and euthanized by jugular exsanguination. Genital tracts
were transported to our laboratory on ice immediately
after animals were euthanized. The endometrium of the
ipsilateral horn to the original corpus luteum was dis-
sected, and fragments of the intercaruncular region weigh-
ing 80–100 mg were conditioned in 12 mm× 75 mm
borosilicate tubes containing 0.5 mL Krebs-Hensleit bicar-
bonate medium (KHB; 118 mmol/L NaCl, 4.7 mmol/L
KCl, 2.56 mmol/L CaCl2, 1.13 mmol/L MgCl2, 25 mmol/L
NaHCO3, 1.15 mmol/L NaH2PO4, 5.55 mmol/L glucose,
20 mmol/L Hepes and 0.013 mmol/L phenol red, pH 7.4).
Cultures were maintained according to procedures de-
scribed by Burns et al. [13]. Tubes containing explants
were kept at 37°C in a shaking waterbath (40 rpm) for 1 h.
Culture media was discarded and explants were washed
twice with 0.5 mL of KHB. Explants were incubated for
1 h in KHB, washed, and then treated in vitro with 1 mL
of either: KHB medium (control); KHB supplemented with
10−5 mol/L A23817, a CI (C-7522, Sigma Chemicals, USA);
KHB supplemented with 10−5 mol/L melittin (M-2272,
Sigma Chemicals, USA); or KHB supplemented with
10−6 mol/L OT (O-6379, Sigma Chemicals, USA). Explants
from each cow received all treatments in triplicate. The
concentrations of drugs we used were based on those
previously reported [13-15]. Samples comprising 100 μL
of culture medium were removed immediately after the
administration of treatments (time 0) and 60 min later.
Samples were stored at −20°C until required. The con-
centration of PGF2α (pg/mL/mg of endometrial tissue)
in the culture medium was measured using radio immuno
assays as described by Danet-Desnoyers et al. [14]. Intra-
assay variation coefficients were 23.7 and 14.1%, and the
inter-assay coefficients were 23.4 and 13.1% for standards
containing 250 and 1,000 pg/mL PGF2α, respectively.
Experiment 2
We obtained BEND cells [16] from the American Type
Culture Collection (ATCC CRL-2398; USA). Cells were
suspended in 4 mL of complete culture medium [40%
HAM F-12 (N6760, Sigma Chemicals, USA); 40% min-
imal essential medium (MEM; M0643, Sigma Chemicals,
USA); 200 IU/L insulin (I5500, Sigma Chemicals, USA);
10% (v/v) fetal bovine serum (FBS; 10270-106, Gibco
Life, USA); 10% (v/v) equine serum (Nutricel, Brazil);
and 1% (v/v) antibiotic and antimycotic solution (A7292,
Sigma Chemicals, USA)] and seeded in 6-well tissue cul-
ture plates (Corning Incorporated, USA). Cells were cul-
tured at 38.5°C/5% CO2 until 90% confluent. Subsequently,
cells were maintained in serum-free medium for 24 h,
washed twice in the same medium, and incubated for 12 h
in 4 mL of serum-free medium supplemented with 0, 10−7,
10−6 or 10−5 mol/L A23817 (C-7522, Sigma Chemicals,
USA) in triplicate wells. Samples of media (500 μL) were
collected immediately after the administration of treat-
ments (time 0) and 12 h later. After sample collection at
time 0, the same volume of medium containing the spe-
cific treatment was replaced in culture wells. Samples
were stored at –20°C until required. Experiments were
repeated three times; intra-assay variation coefficients
were 13.2 and 18.8%, and inter-assay variation coeffi-
cients were 10.3 and 22.0% for standards containing 250
and 1,000 pg/mL PGF2α, respectively.
Experiment 3
We seeded BEND cells in 24-well plates (4 × 104 cells/well;
Corning Incorporated) with 1.5 mL of complete culture
medium. Cultures were incubated at 38.5°C/5% CO2 until
cells were 90% confluent. Cells were then cultured in
serum-free medium for 24 h, washed twice with the same
medium, and incubated for 12 h in serum-free medium
supplemented with 10−13 mol/L E2 (E-8875, Sigma Che-
micals, USA) and 10−6 mol/L A23817 (Sigma Chemicals,
USA). Control wells received serum-free medium without
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supplements; all experiments were conducted in triplicate.
Samples of media (300 μL) were collected immediately
after the administration of drugs (time 0) and 12 h later.
After sample collection at time 0, the same volume of
medium containing the specific treatment was replaced
in wells. Samples were stored at –20°C until subsequent
measurement of PGF2α concentration. Experiments were
conducted three times; intra-assay variation coefficients
were 16.0 and 20.6%, and the inter-assay variation coeffi-
cients were 4.0 and 18.9% for standards containing 250
and 1,000 pg/mL PGF2α, respectively.
Statistical analysis
Data that did not meet the assumptions of normality of
residues (Shapiro-Wilk Test, P ≤ 0.01) or homogeneity of
variances (F Test, P ≤ 0.01) were transformed by square
roots and reanalyzed. Data were analyzed by ANOVA
using the GLM procedure with the SAS program and
are presented as untransformed least squares means ±
SEM. Treatment means were compared by orthogonal
contrasts. In Experiment 1, the dependent variable was
DIF60 (the difference between PGF2α concentrations at
0 and 60 min), and the independent variable was treat-
ment. For Experiments 2 and 3 the dependent variable
was DIF12 (the difference between PGF2α concentra-
tions at 0 and 12 h) and the independent variables were
experiment, treatment and the interaction between ex-
periment and treatment. Statistical significance was
considered at P < 0.05.
Results
Experiment 1
The DIF60 for the various treatments are shown in
Table 1. Endometrial explants that remained untreated
in vitro produced similar concentrations of PGF2α whether
they were obtained from cows injected with E2 (3 mg)
(20.7 ± 4.2 pg/mL/mg of tissue) or not (24.7 ± 4.6 pg/mL/mg
of tissue; Table 1). Regarding control animals, PGF2α
synthesis was similar among untreated explants (24.7 ±
4.6 pg/mL/mg of tissue) and explants treated with
OT (28.2 ± 4.6 pg/mL/mg of tissue), melittin (26.9 ±
5.0 pg/mL/mg of tissue) or A23187 (29.0 ± 4.6 pg/mL/mg
of tissue; Table 1). In contrast, synthesis of PGF2α from
explants originating from animals treated with E2 was
48.4% greater following exposure to A23817 (43.0 ± 4.2
pg/mL/mg of tissue) compared with explants from control
animals (29.0 ± 4.6 pg/mL/mg of tissue; P≤ 0.01). Treat-
ment with E2 in vivo did not affect the responses to melit-
tin (26.9 ± 5.0 vs. 31.7 ± 4.6 pg/mL/mg of tissue) or OT
(28.2 ± 4.6 vs. 33.2 ± 4.2 pg/mL/mg of tissue).
Experiment 2
We used A23187 at 10−7, 10−6 and 10−5 mol/L, and these
concentrations stimulated dose-dependent increase in
PGF2α production (Figure 1). A23187 stimulated the syn-
thesis of PGF2α in all treatment groups compared with
that seen in the control group (P≤ 0.01). The level of
stimulation was greater when A23187 was used at 10−6
and 10−5 mol/L, in comparison with A23817 at 10−7 mol/L
(P≤ 0.01). We did not observe a significant difference in
stimulation levels between 10−6 and 10−5 mol/L A23817.
Experiment 3
Mean PGF2α concentrations were 33.1, 32.5, 92.4 and
145.6 pg/mL (SEM: 21.8 pg/mL) for untreated cells, cells
treated with E2, cells treated with A23817, and cells
treated with E2 and A23817, respectively (Figure 2). Pro-
duction of PGF2α was similar between cells treated with
E2 and untreated cells. The cells treated with A23817
tended (P ≤ 0.08) to produce higher quantities of PGF2α
compared with cells treated with E2, or cells that were
left untreated . The combination of E2 and A23817 stim-
ulated greater synthesis of PGF2α compared with the
other treatments (P < 0.01). A23817 was responsible for
a 179% increase in PGF2α production relative to the
control group. When A23817 was combined with E2, the
production of PGF2α increased by 340% compared with
that in the control group.
Discussion
In Experiment 1, PGF2α synthesis was not stimulated in
the endometrial explants from cows treated with E2
in vivo and received no treatment in vitro (Table 1).
These results oppose those reported by Mann [17]. In
contrast, Asselin et al. [18] and Xiao et al. [19] reported
that the addition of E2 to the culture medium was not
able to stimulate the release of PGF2α. Because of the
inconsistencies in the previously reported data, it was
considered appropriate to administer E2 in vivo in this
experiment. Previous reports indicated that the adminis-
tration of E2 could stimulate the production of PGFM in
cows on days 13 [2,20,21], 17 [20-22], 18 [1,20,23] and
19 [21] of the estrous cycle. Bertan et al. [21] verified
that E2 promoted an increase in the plasma concentra-
tion of PGFM 4 h after injection; its concentration
peaked within 6.5 h and returned to basal levels 9 h after
Table 1 Concentration of PGF2α (pg/mL/mg of tissue)
produced by endometrial explants from cross-bred
heifers on Day 17 of the estrous cycle treated in vivo
with 17β-estradiol and in vitro with A23817, melittin or OT
Variable Treatment (mean ± SEM)
Control E2 Stimulator E2/Stimulator
DIF60 –A23817 24.7 ± 4.6b 20.7 ± 4.2b 29.0 ± 4.6b 43.0 ± 4.2a
DIF60 - melittin 24.7 ± 4.6 20.7 ± 4.2 26.9 ± 5.0 31.7 ± 4.6
DIF60 - OT 24.7 ± 4.6 20.7 ± 4.2 28.2 ± 4.6 33.2 ± 4.2
a,bsignificantly different, P ≤ 0.01.
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treatment. Given this time frame, it was considered appro-
priate to administer E2 in vivo 2 h prior to euthanizing
cows. This procedure allowed the explants to be incubated
with different stimulants approximately 6.5 h after the E2
injection.
It was expected that E2 would stimulate the synthesis
of enzymes involved in the synthesis of PGF2α. Thus, E2
would increase the concentrations of the corresponding
proteins in cellular compartments. It was also expected
that the activity of these proteins during PGF2α produc-
tion would be amplified following specific stimulation.
The CI A23817 promotes an increase in intracellular cal-
cium concentration that is responsible for the activation
of PKC and PLA2. The stimulant melittin specifically acti-
vates PLA2. Melittin and A23817 increase the synthesis of
PGF2α in ovine [13,24] and bovine endometrial explants
[13,14,17,25,26]; however, this stimulation was not observed
in our studies when A23817, melittin or OT was used on
their own.
In our Experiment 1, synthesis of PGF2α was observed
only when A23817 was used in combination with E2.
Other researchers observed that the effects of E2 were
frequently associated with an increase in the concentra-
tions of free calcium in the cytosol [27-29]. We suggest
that PKC and PLA2 are present in greater concentra-
tions in the explants from animals treated in vivo with
E2. Increased production of PGF2α would result in re-
sponse to this greater concentration of enzymes stimu-
lated by A23817. However, it is possible that higher
concentrations of PLA2 in the endometrial explants that
were previously exposed to E2 could amplify the synthe-
sis of PGF2α in the presence of melittin. This could be
explained by the fact that calcium is likely to be the
major limiting factor in the activation of PLA2. In
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Figure 1 PGF2α production after 12 h in the culture medium of bovine endometrial (BEND) cells treated with A23817 (DIF12).
a,b,csignificantly different, P < 0.01.
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Figure 2 PGF2α production after 12 h in the culture medium of BEND cells treated with estradiol and/or A23817 (DIF12). a,bsignificantly
different, P < 0.01.
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summary, we suggest that higher concentrations of PKC
and PLA2 were present in the explants treated with E2,
and that these enzymes promoted an increase in the syn-
thesis of PGF2α in the presence of A23817.
In Experiment 2 (Figure 1), A23817 stimulated the
synthesis of PGF2α for all treatment groups. When
A23817 was administered at doses of 10−6 and 10−5 mol/L,
stimulation was greater than that when the CI was used at
10−7 mol/L. The capacity of BEND cells to synthesize
PGF2α [30-32] and the cellular model for the synthesis of
PGF2α described by Burns et al. [13] indicate that calcium
is responsible for the activation of enzymes such as PKC
and PLA2. These enzymes are essential for the synthesis
of PGF2α by endometrial cells. Treatment with a CI has
stimulated PGF2α synthesis in endometrial explants
from sows [33], guinea pigs [34,35], ewes [36-38] and
cows [14,15,39].
In our study, CI stimulated PGF2α synthesis in BEND
cells in a dose-dependent manner. Other studies have
verified the dose-dependent effects of CI on the synthe-
sis of PGF2α in endometrial explants. Lafrance and Goff
[40] observed that a CI at 2.6 μg/mL was sufficient to
stimulate the synthesis of PGF2α in the endometrial ex-
plants of heifers on days 19 or 20 of the estrous cycle.
Danet-Desnoyers et al. [14] reported that the biosyn-
thesis of PGF2α stimulated by a CI in the endometrium
of cows on day 17 of the estrous cycle exhibited a dose-
dependent response. Synthesis was increased by 0, 67
and 107% when doses of 2, 4 and 10 μg/mL were admin-
istered, respectively. In the present experiment, doses of
0.052 (10−7 mol/L), 0.52 (10−6 mol/L), and 5.2 μg/mL
(10−5 mol/L) increased the production of PGF2α by 46,
105 and 661%, respectively. We propose that lower doses
of A23817 stimulate the synthesis of PGF2α in BEND
cells, with a significantly amplified response compared
with that in endometrial explants. The increase in intra-
cellular calcium concentration is associated with PLA2
activity [41,42] and in the increased availability of AA
for the synthesis of PGF2α [41]. Arnold et al. [15] veri-
fied that the synthesis of PGF2α was stimulated in bovine
endometrium cultured with a CI, regardless of whether it
was supplemented with PLA2. Synthesis was greater when
the endometrium was treated with a CI and PLA2 com-
pared with explants treated with PLA2 alone. We propose
that calcium has an additive effect on the stimulation of
PLA2-induced synthesis of PGF2α.
Our hypothesis for Experiment 3 was that E2 increases
the sensitivity of endometrial cells to calcium. We verified
that A23817 promoted an increase of 179% in the produc-
tion of PGF2α compared with untreated cells. However,
when A23817 was used in combination with E2, this in-
crease was approximately 340% (Figure 2), similar to our
results in Experiment 1. Thus, E2 increased the sensitivity
of endometrial cells to calcium, supporting the hypothesis
of our experiment. Several researchers reported that the
synthesis of PGF2α by endometrial explants was not in-
creased by supplementing cultures with E2 [26,43,44].
Consistently, in Experiment 3, synthesis of PGF2α was not
stimulated in BEND cells treated with E2 only. The gen-
omic action of E2 is promoted by the E2-receptor complex,
which activates transcription factors that are bound to
DNA, ultimately resulting in new protein synthesis [29].
In vivo, E2 most likely activates the synthesis of PGF2α by
stimulating the transcription and translation of proteins
involved in the production of PGF2α. However, the activ-
ity of E2-induced proteins might need further stimulation
in vitro because of limited access to calcium under culture
conditions. In our study, the addition of A23817 to BEND
cell cultures increased intracellular calcium concentra-
tions, to enhance intracellular mechanisms that depend
on this ion. Therefore, PKC and PLA2, which are involved
in the synthesis of PGF2α, might have been activated, to
increase synthesis of PGF2α.
In summary, from our experiments, E2 did not stimulate
the synthesis of PGF2α by endometrial cells and explants
cultured in vitro. Many other in vitro studies have shown
that the administration of E2 alone in endometrial ex-
plants does not stimulate PGF2α synthesis [26,43,44]. We
suggest that the participation of E2 in the synthesis of
PGF2α involves other endocrine and paracrine factors that
are absent in cell and explant culture systems. Bertan et al.
[21] clearly showed that E2 did not immediately affect the
cows that were treated on day 17 of the estrous cycle. The
interval between the injection of E2 and the increase in
PGFM serum concentrations suggests that E2 acts on
the synthesis of PGF2α through a genomic pathway. We
speculate that E2 directly stimulates the synthesis of
proteins involved in PGF2α production; these proteins
might include PKC and PLA2, as they contain calcium-
dependent activation domains. Further studies are re-
quired to test this proposition.
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